Metastasized ovarian cancer cells showed upregulation of fatty acid binding protein 4 (FABP4), especially in the adipocyte–tumor interface and pharmacological inhibition of FABP4 substantially impaired ovarian metastases in mice.34 This evidence concerns the gene FABP4 and ovarian carcinoma.